Clarus Wealth Advisors Incyte Corp Transaction History

Clarus Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	SELL	$72.82 - $86.52 $2,767 - $3,287	-38 Closed	0 $0
Q1 2019 Apr 04, 2019	SELL	$63.56 - $88.17 $31,780 - $44,085	-500 Reduced 92.94%	38 $3,000
Q4 2018 Jan 08, 2019	BUY	$58.5 - $69.94 $31,473 - $37,627	538 New	538 $37,000
Q4 2018 Jan 07, 2019	SELL	$58.5 - $69.94 $31,473 - $37,627	-538 Closed	0 $0
Q3 2018 Oct 03, 2018	BUY	$61.75 - $74.23 $33,221 - $39,935	538 New	538 $37,000

629

198M

766K

476K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $14.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.